![]() |
市場調査レポート
商品コード
1541202
家禽診断市場レポート:疾病タイプ、検査タイプ、サービス、地域別、2024年~2032年Poultry Diagnostics Market Report by Disease Type, Test Type, Service, and Region 2024-2032 |
||||||
カスタマイズ可能
|
家禽診断市場レポート:疾病タイプ、検査タイプ、サービス、地域別、2024年~2032年 |
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2~3営業日
|
家禽診断市場の世界市場規模は2023年に4億8,680万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに10億7,320万米ドルに達し、2024年から2032年の間に8.9%の成長率(CAGR)を示すと予測しています。家禽消費量の増加、鳥インフルエンザやニューカッスル病の頻繁な発生、厳しい食品安全規制、大幅な技術進歩、家禽の発生に伴う経済的損失に対する意識の高まり、この分野における研究開発の継続などが市場を牽引する主な要因です。
家禽診断学は、家禽産業における重要な側面であり、家禽群における疾病と健康問題の特定と管理に焦点を当てています。家禽の健康を確保する上で極めて重要な役割を担っており、ひいては消費者に提供する家禽製品の品質を守ることにもつながっています。これらの診断には、実験室での検査、臨床検査、高度な画像技術など、様々な技術が含まれます。家禽診断の第一の目的は、鳥インフルエンザ、ニューカッスル病、コクシジウム症などの疾病を迅速に発見し、対処することです。群れ内での病気の蔓延を防ぎ、経済的損失を減らし、食品安全基準を維持するためには、早期発見が不可欠です。さらに、効果的なワクチン接種や治療戦略の開発にも役立ちます。
手ごろな価格で無駄のないタンパク源としての鶏肉製品に対する世界の需要の増加は、主要な促進要因です。このような消費の急増により、家禽群の健康と安全を確保するための強固な診断が必要となります。さらに、鳥インフルエンザやニューカッスル病のような疾病の頻繁な発生は、家禽生産の脆弱性を浮き彫りにしています。このため、疾病を迅速に特定し、封じ込めるための診断ツールへの投資が拡大しています。この他にも、養鶏業者は疾病の発生に伴う経済的損失について、ますます認識するようになっています。このような認識により、生産者は自らの家禽群と収益を守るため、積極的な診断対策に投資するようになっています。これに加えて、世界各国の政府は、鶏肉製品を含む食品の安全性に関する規制を強化しています。これらの規制を遵守し、消費者の信頼を維持するためには、家禽の診断が不可欠です。これに伴い、PCRやELISAなどの診断技術の進歩により、疾病検出のスピードと精度が向上しています。このことが、養鶏業界におけるこれらの診断法の採用に拍車をかけています。さらに、家禽診断の分野で進行中の研究は、より洗練された効果的な診断ツールの開発につながり、投資と市場の成長の両方を引き寄せています。
家禽消費量の増加
鶏や七面鳥などの家禽類は、増加する世界人口にとって手頃な価格で高品質なタンパク質の重要な供給源です。より多くの人々が食卓に家禽を取り入れる中、この需要に応えるために家禽群の健康と安全を確保する必要性が高まっています。家禽診断は、家禽の健康を維持する上で重要な役割を担っており、これは消費に供される家禽製品の質と量に直接影響します。健康な群れは生産性が高く、病気の発生が少ないため、養鶏事業の全体的な効率化に貢献します。したがって、家禽消費量の増加は、家畜の健康と食の安全の両方を守るための効果的な診断薬に対する需要と本質的に関連しています。
頻発する疾病の発生
これらの疾病は群れの中で急速に蔓延する可能性があり、養鶏業者にとって大きな経済的損失につながります。これに対し、養鶏業界は疾病の早期発見と管理の重要性を認識しています。家禽用診断薬は、このようなアウトブレイクの原因となる病原体の存在を迅速に特定するために不可欠なツールです。迅速な診断により、検疫やワクチン接種などの管理措置をタイムリーに実施し、病気の蔓延を抑え、経済的損失を抑えることができます。疾病の発生により家禽生産が大規模に中断される可能性があるため、家禽診断が家禽産業の持続可能性のための基本的な投資となっています。
厳しい食品安全規制
政府および規制機関は、消費者に対する鶏肉製品の安全性確保をより重視しています。これには、家禽から人へ感染する可能性のある疾病の監視と管理も含まれます。家禽用診断薬は、このような規制要件を満たす上で極めて重要な役割を果たします。これにより、家禽生産者は厳格な衛生・安全基準を遵守していることを証明することができ、家禽製品に病気を引き起こす病原体が含まれていないことを保証することができます。これらの規制を遵守しない場合、製品の回収、法的措置、企業の評判の低下につながる可能性があります。
The global poultry diagnostics market size reached US$ 486.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,073.2 Million by 2032, exhibiting a growth rate (CAGR) of 8.9% during 2024-2032. The rising poultry consumption, frequent outbreaks of avian influenza and Newcastle disease, stringent food safety regulations, significant technological advancements, growing awareness about the economic losses associated with poultry outbreaks, and ongoing research and development activities in this field are some of the key factors driving the market.
Poultry diagnostics is a crucial aspect of the poultry industry, focusing on the identification and management of diseases and health issues in poultry flocks. It plays a pivotal role in ensuring the well-being of poultry birds, which, in turn, safeguards the quality of poultry products for consumers. These diagnostics encompass a range of techniques, including laboratory tests, clinical examinations, and advanced imaging technologies. The primary objective of poultry diagnostics is to promptly detect and address diseases, such as avian influenza, Newcastle disease, and coccidiosis, among others. Early detection is vital to prevent the spread of diseases within flocks, reduce economic losses, and maintain food safety standards. Moreover, it aids in the development of effective vaccination and treatment strategies.
The increasing global demand for poultry products as a source of affordable and lean protein is a primary driver. This surge in consumption necessitates robust diagnostics to ensure the health and safety of poultry flocks. Additionally, frequent outbreaks of diseases like avian influenza and Newcastle disease have highlighted the vulnerability of poultry production. This has led to greater investments in diagnostic tools to quickly identify and contain diseases. Other than this, poultry producers are becoming increasingly aware about the economic losses associated with disease outbreaks. This awareness drives them to invest in proactive diagnostic measures to protect their flocks and bottom lines. Besides this, governments worldwide are enforcing stricter regulations on food safety, including poultry products. Poultry diagnostics are essential for compliance with these regulations and to maintain consumer trust. In line with this, advances in diagnostic technologies, such as PCR and ELISA, have enhanced the speed and accuracy of disease detection. This has spurred the adoption of these diagnostic methods in the poultry industry. Furthermore, ongoing research in the field of poultry diagnostics is leading to the development of more sophisticated and effective diagnostic tools, attracting both investments and market growth.
Rising Poultry Consumption
Poultry, such as chickens and turkeys, is a significant source of affordable and high-quality protein for a growing global population. As more people include poultry in their diets, there is a greater need to ensure the health and safety of poultry flocks to meet this demand. Poultry diagnostics play a critical role in maintaining the health of these birds, which directly impacts the quality and quantity of poultry products available for consumption. Healthy flocks are more productive and less prone to disease outbreaks, contributing to the overall efficiency of poultry farming operations. Therefore, the rise in poultry consumption is intrinsically linked to the demand for effective diagnostics to safeguard both animal health and food safety.
Frequent Disease Outbreaks
These diseases can spread rapidly within flocks, leading to significant economic losses for poultry producers. In response, the poultry industry has recognized the critical importance of early detection and management of diseases. Poultry diagnostics are indispensable tools for swiftly identifying the presence of pathogens responsible for these outbreaks. Rapid diagnosis allows for timely implementation of control measures, such as quarantine and vaccination, to contain the spread of the disease and limit economic losses. The potential for large-scale disruptions in poultry production due to disease outbreaks has made poultry diagnostics a fundamental investment for the sustainability of the industry.
Stringent Food Safety Regulations
Governments and regulatory bodies are placing greater emphasis on ensuring the safety of poultry products for consumers. This includes monitoring and controlling diseases that can be transmitted from poultry to humans. Poultry diagnostics play a pivotal role in meeting these regulatory requirements. They enable poultry producers to demonstrate compliance with strict health and safety standards, ensuring that poultry products are free from disease-causing agents. Failure to adhere to these regulations can result in product recalls, legal consequences, and damage to a reputation of a company.
IMARC Group provides an analysis of the key trends in each segment of the market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on disease type, test type, and service.
Avian Influenza
Avian Salmonellosis
Avian Mycoplasmosis
Infectious Bronchitis
Infectious Bursal Disease
Newcastle Disease
Chicken Anemia
Others
Avian Influenza accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the disease type. This includes avian influenza, avian salmonellosis, avian mycoplasmosis, infectious bronchitis, Newcastle disease, chicken anemia, and others. According to the report, Avian Influenza represented the largest segment.
Avian influenza, commonly known as bird flu, poses a significant threat to the global poultry industry due to its highly contagious nature and potential for rapid transmission within poultry flocks. This heightened risk has prompted poultry producers to prioritize avian influenza diagnostics as a proactive measure to protect their flocks. Additionally, avian influenza has garnered substantial attention from governments and international organizations due to its zoonotic potential, meaning it can be transmitted from birds to humans. This dual threat to animal and human health has led to stringent monitoring and control measures, further driving the demand for avian influenza diagnostics to ensure early detection and containment. Moreover, avian influenza outbreaks can result in devastating economic losses, including mass culling of infected birds, trade restrictions, and decreased consumer confidence in poultry products. Therefore, the economic implications of avian influenza outbreaks have incentivized poultry producers to invest significantly in avian influenza diagnostics as part of their risk mitigation strategies.
ELISA test
PCR Test
Others
ELISA test holds the largest share in the industry
A detailed breakup and analysis of the market based on the test type has also been provided in the report. This includes ELISA test, PCR test, and others. According to the report, ELISA test accounted for the largest market share.
ELISA is renowned for its versatility and wide applicability in detecting a broad spectrum of poultry diseases, including avian influenza, Newcastle disease, and salmonellosis, among others. This versatility makes it a preferred choice for many poultry producers and diagnostic laboratories as a comprehensive diagnostic tool. Besides this, ELISA tests offer high sensitivity and specificity, ensuring accurate and reliable results. The poultry industry places a premium on precise disease detection to make informed decisions promptly, such as initiating disease control measures or treatment protocols. Furthermore, ELISA tests are relatively cost-effective when compared to some other diagnostic methods, making them an attractive option for poultry producers seeking efficient disease management without significantly increasing operational costs. Additionally, the well-established nature of ELISA technology, along with a wealth of validated assays, instills confidence in its effectiveness among industry professionals and regulatory bodies. This confidence in reliability of ELISA and its track record of successful disease management contributes to its status as the largest segment in the market by test type.
Bacteriology
Parasitology
Virology
Bacteriology represents the leading market segment
The report has provided a detailed breakup and analysis of the market based on the service. This includes bacteriology, parasitology, and virology. According to the report, bacteriology represented the largest segment.
Bacteria play a pivotal role in poultry health, as bacterial infections can quickly spread within flocks and lead to severe economic losses. Bacteriology services encompass the isolation, identification, and characterization of bacterial pathogens responsible for various poultry diseases. This includes common issues like Salmonella and E. coli infections, which have significant implications for both poultry health and food safety. Moreover, food safety regulations and consumer demand for safe poultry products have intensified the focus on bacterial pathogens in poultry. As a result, poultry producers and processors rely heavily on bacteriology services to ensure that their products meet stringent safety standards and do not pose health risks to consumers. Furthermore, continuous research and innovation in bacteriology have led to the development of advanced diagnostic techniques, such as DNA sequencing and molecular methods, which offer higher specificity and sensitivity. This has further solidified position of bacteriology as the largest segment in the poultry diagnostics market by service, addressing critical needs for both animal health and public health.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America leads the market, accounting for the largest poultry diagnostics market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America has a well-established and highly industrialized poultry sector, with the United States being one of the largest poultry producers globally. This substantial poultry production requires rigorous disease management to ensure the health and safety of poultry flocks and the quality of poultry products, creating a substantial demand for diagnostic services and tools. Additionally, the region places a strong emphasis on food safety and consumer health. Stringent regulatory frameworks and consumer expectations for safe poultry products have spurred investments in advanced diagnostic technologies to detect and manage diseases effectively, thus supporting the growth of the poultry diagnostics market. Other than this, North America benefits from a mature healthcare and veterinary infrastructure, fostering the adoption of cutting-edge diagnostic methods. The presence of leading diagnostic companies, research institutions, and veterinary clinics further contributes to the availability and utilization of poultry diagnostics in the region. Furthermore, the proactive approach of North America to research and development in the poultry industry ensures a continuous flow of innovation in diagnostics, meeting the evolving needs of the sector.
Leading companies in the poultry diagnostics sector are heavily investing in R&D. They are developing innovative diagnostic tools and technologies that offer higher sensitivity, specificity, and speed in disease detection. This commitment to innovation ensures that poultry producers have access to state-of-the-art diagnostics to safeguard their flocks. Additionally, numerous key players are forming strategic partnerships with research institutions and veterinary organizations. These collaborations foster knowledge exchange, allowing for the development of cutting-edge diagnostic solutions. Partnerships also help in expanding market reach and ensuring the widespread adoption of advanced diagnostic technologies. Other than this, recognizing the global nature of the poultry industry, key players are expanding their presence in various regions. This involves setting up distribution networks, establishing subsidiaries, and entering emerging markets with high poultry production potential. By offering their diagnostic products and services worldwide, these companies are capitalizing on the growing demand for poultry diagnostics. Furthermore, tailoring diagnostic solutions to the specific needs of poultry producers is a notable strategy. Key players are offering customized diagnostic packages that address the unique challenges faced by different poultry operations. This approach enhances customer satisfaction and fosters long-term partnerships.
AgroBioTek Laboratories
BioChek B.V.
Bionote Co. Ltd.
Boehringer Ingelheim International GmbH
IDEXX Laboratories Inc.
MEGACOR Diagnostik GmbH
QIAGEN N.V.
Gezondheidsdienst voor Dieren B.V. (Royal GD)
Thermo Fisher Scientific Inc.
Zoetis Inc.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
In 2022, IDEXX Laboratories Inc has announced the launch of a number of new diagnostic tests, as well as a new software application that helps farmers and producers to manage their poultry health. It has also introduced rapid testing methods and diagnostic assays that provide quick and accurate results for poultry diseases.
Qiagen, a leading player in the poultry diagnostics market, has focused on developing molecular diagnostic solutions for the poultry industry. It has launched advanced DNA and RNA-based tests to detect various pathogens and diseases in poultry.
Thermo Fisher Scientific Inc has been actively involved in the poultry diagnostics market. It has developed innovative solutions such as PCR-based testing kits and advanced diagnostic instruments to detect poultry diseases accurately.